Methadone-Associated Mortality: Report of a National Assessment

Contents: Conference Papers

(These documents, in HTML format, are available at http://www.samhsa.gov.)

Background Briefing Report

Presentation Summaries and Speakers' Slides and Handouts

Part 1. Introductory Remarks: Alan Trachtenberg, MD, MPH (SAMHSA/CSAT)

Part 2. The Opioid Treatment Program (OTP) Perspective: Mark W. Parrino, MPA, Meeting Co-Chair and President of The American Association for the Treatment of Opioid Dependency (AATOD)

Part 3. Clinical Importance of Methadone in Opioid Agonist Therapy (OAT) and Pain Management: Seddon Savage, MD, Meeting Co-Chair

Part 4. Challenges to Forensic Science: Bruce A. Goldberger, PhD, DABFT, Meeting Co-Chair

Part 5. Drug Abuse Warning Network (DAWN) and Other SAMHSA Office of Applied Studies Data: Elizabeth Crane, PhD, MPH (SAMHSA)

Part 6. Opioid Utilization Data: Automation of Reports and Consolidated Order System (ARCOS): June E. Howard, Chief of the Targeting and Analysis Unit in the Drug Operations Section, Office of Diversion Control, Drug Enforcement Administration (DEA)

Part 7. Opioid Utilization Data: IMS Health: Laura Governale, PharmD, Food and Drug Administration's (FDA) Office of Drug Safety, Division of Surveillance, Research and Communication Support

Part 8. Methadone Mortality Data from MedWatch: Rita Ouellete-Hellstrom, PhD, Martin Pollock, PharmD, and Lanh Green, PhD, FDA Office of Drug Safety

Part 9. Surveillance of Medication-Related Mortality and Morbidity: Dan Budnitz, MD, MPH, Centers for Disease Control and Prevention (CDC) National Center for Prevention and Control

Part 10. Cardiac Questions: Mori J. Krantz, MD, Associate Professor of Medicine and Cardiology, Denver Health

Part 11. New Population Based Data: Bridget Martell, MD, MA, Medical Director, Melrose-on-Track Clinic, Albert Einstein College of Medicine

Part 12. Trends in Fatal Opioid Poisoning-National Numerator and Death Certificate Data: Lois A. Fingerhut, MA, CDC's National Center for Health Services

Part 13. State-Level Data: North Carolina: Catherine Sanford, MSPH, Public Health Epidemiologist, North Carolina Department of Health and Human Services

Part 14. State-Level Data: Maine: Marcella H. Sorg, PhD, RN, University of Maine

Part 15. State-Level Data: Washington and Virginia: Ann Marie Gordon, MS, State of Washington Toxicology Laboratory

Part 16. State-Level Data: Texas: Jane C. Maxwell, PhD, Gulf Coast Addiction Technology Transfer Center, University of Texas at Austin

Part 17. National Violent Death Reporting System (NVDRS): Randy L. Hanzlick, MD, Chief Medical Examiner for Fulton County, Georgia

Part 18. National Association of Medical Examiners (NAME) Pediatric Toxicology Registry: John D. Howard, MD, Chief Medical Examiner for Pierce County, Washington

Part 19. Consumer Product Safety Commission's Use of Death Certificates: Tom Schroeder, MS, Consumer Product Safety Commission

Part 20. Electronic Prescription Monitoring Programs: Dana Droz, JD, Kentucky

Part 21. Review of Methadone Related Deaths in Ontario: Douglas Gourlay, MD, Anesthesiologist and Medical Consultant, Toronto, Ontario